The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Fludarabine phosphate oral tablets (Brand name: Fludarabine (oral))
- Manufactured by
FDA-approved indication: Treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not responded to or has progressed during or after treatment with at least one standard alkylating-agent containing regimen.
National Library of Medicine Drug Information PortalMedline Plus Health Information